{"id":"https://openalex.org/W2125337286","doi":null,"title":"Efficacy of combination chemotherapy using a novel oral chemotherapeutic agent, TAS-102, with irinotecan hydrochloride on human colorectal and gastric cancer xenografts.","display_name":"Efficacy of combination chemotherapy using a novel oral chemotherapeutic agent, TAS-102, with irinotecan hydrochloride on human colorectal and gastric cancer xenografts.","publication_year":2015,"publication_date":"2015-03-01","ids":{"openalex":"https://openalex.org/W2125337286","mag":"2125337286","pmid":"https://pubmed.ncbi.nlm.nih.gov/25750295"},"language":"en","primary_location":{"id":"pmid:25750295","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/25750295","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anticancer research","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5084347479","display_name":"Mamoru Nukatsuka","orcid":"https://orcid.org/0000-0001-9774-2526","observed_orcids":["https://orcid.org/0000-0001-9774-2526"]},"institutions":[{"id":"https://openalex.org/I4210120269","display_name":"Taiho Pharmaceutical (Japan)","ror":"https://ror.org/02v50dx14","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210120269"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Mamoru Nukatsuka","raw_affiliation_strings":["Translational Research Laboratory, Tokushima Research Center, Taiho Pharmaceutical Co., Ltd., Tokushima, Japan m-nukatsuka@taiho.co.jp"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Translational Research Laboratory, Tokushima Research Center, Taiho Pharmaceutical Co., Ltd., Tokushima, Japan m-nukatsuka@taiho.co.jp","institution_ids":["https://openalex.org/I4210120269"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108833734","display_name":"Fumio Nakagawa","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210120269","display_name":"Taiho Pharmaceutical (Japan)","ror":"https://ror.org/02v50dx14","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210120269"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Fumio Nakagawa","raw_affiliation_strings":["Applied Pharmacology Laboratory, Tokushima Research Center, Taiho Pharmaceutical Co., Ltd., Tokushima, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Applied Pharmacology Laboratory, Tokushima Research Center, Taiho Pharmaceutical Co., Ltd., Tokushima, Japan","institution_ids":["https://openalex.org/I4210120269"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006884303","display_name":"Hitoshi Sait\u00f4","orcid":"https://orcid.org/0000-0002-5973-1364","observed_orcids":["https://orcid.org/0000-0002-5973-1364"]},"institutions":[{"id":"https://openalex.org/I4210120269","display_name":"Taiho Pharmaceutical (Japan)","ror":"https://ror.org/02v50dx14","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210120269"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Hitoshi Saito","raw_affiliation_strings":["Applied Pharmacology Laboratory, Tokushima Research Center, Taiho Pharmaceutical Co., Ltd., Tokushima, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Applied Pharmacology Laboratory, Tokushima Research Center, Taiho Pharmaceutical Co., Ltd., Tokushima, Japan","institution_ids":["https://openalex.org/I4210120269"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002930066","display_name":"Minoru Sakata","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210120269","display_name":"Taiho Pharmaceutical (Japan)","ror":"https://ror.org/02v50dx14","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210120269"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Minoru Sakata","raw_affiliation_strings":["Applied Pharmacology Laboratory, Tokushima Research Center, Taiho Pharmaceutical Co., Ltd., Tokushima, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Applied Pharmacology Laboratory, Tokushima Research Center, Taiho Pharmaceutical Co., Ltd., Tokushima, Japan","institution_ids":["https://openalex.org/I4210120269"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001730366","display_name":"Junji Uchida","orcid":"https://orcid.org/0000-0002-0113-8058","observed_orcids":["https://orcid.org/0000-0002-0113-8058","https://orcid.org/0000-0003-3629-6686"]},"institutions":[{"id":"https://openalex.org/I4210120269","display_name":"Taiho Pharmaceutical (Japan)","ror":"https://ror.org/02v50dx14","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210120269"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Junji Uchida","raw_affiliation_strings":["Applied Pharmacology Laboratory, Tokushima Research Center, Taiho Pharmaceutical Co., Ltd., Tokushima, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Applied Pharmacology Laboratory, Tokushima Research Center, Taiho Pharmaceutical Co., Ltd., Tokushima, Japan","institution_ids":["https://openalex.org/I4210120269"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5058238996","display_name":"Teiji Takechi","orcid":"https://orcid.org/0000-0001-8552-9170","observed_orcids":["https://orcid.org/0000-0001-8552-9170"]},"institutions":[{"id":"https://openalex.org/I4210120269","display_name":"Taiho Pharmaceutical (Japan)","ror":"https://ror.org/02v50dx14","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210120269"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Teiji Takechi","raw_affiliation_strings":["Translational Research Laboratory, Tokushima Research Center, Taiho Pharmaceutical Co., Ltd., Tokushima, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Translational Research Laboratory, Tokushima Research Center, Taiho Pharmaceutical Co., Ltd., Tokushima, Japan","institution_ids":["https://openalex.org/I4210120269"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210120269"],"apc_list":null,"apc_paid":null,"fwci":3.1443,"has_fulltext":false,"cited_by_count":37,"citation_normalized_percentile":{"value":0.93921825,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"35","issue":"3","first_page":"1437","last_page":"45"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.0026000000070780516,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/trifluridine-tipiracil","display_name":"trifluridine/tipiracil","score":1.0},{"id":"https://openalex.org/keywords/irinotecan","display_name":"irinotecan","score":0.8429999947547913},{"id":"https://openalex.org/keywords/combination-chemotherapy","display_name":"combination chemotherapy","score":0.925000011920929},{"id":"https://openalex.org/keywords/colorectal-cancer","display_name":"colorectal cancer","score":0.9269999861717224},{"id":"https://openalex.org/keywords/gastric-cancer","display_name":"gastric cancer","score":1.0},{"id":"https://openalex.org/keywords/xenografts","display_name":"xenografts","score":0.746999979019165},{"id":"https://openalex.org/keywords/trifluridine","display_name":"trifluridine","score":0.8109999895095825},{"id":"https://openalex.org/keywords/tipiracil","display_name":"tipiracil","score":0.9860000014305115},{"id":"https://openalex.org/keywords/5-fluorouracil-resistance","display_name":"5-fluorouracil resistance","score":0.8669999837875366},{"id":"https://openalex.org/keywords/recurrent-cancer","display_name":"recurrent cancer","score":0.5260000228881836},{"id":"https://openalex.org/keywords/tumor-growth-inhibition","display_name":"tumor growth inhibition","score":0.9089999794960022}],"concepts":[{"id":"https://openalex.org/C2780259306","wikidata":"https://www.wikidata.org/wiki/Q412197","display_name":"Irinotecan","level":4,"score":0.8884116411209106},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8180773258209229},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.7072979211807251},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.6356399655342102},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5784162878990173},{"id":"https://openalex.org/C2780456651","wikidata":"https://www.wikidata.org/wiki/Q238512","display_name":"Fluorouracil","level":3,"score":0.5489658117294312},{"id":"https://openalex.org/C142424586","wikidata":"https://www.wikidata.org/wiki/Q7307572","display_name":"Refractory (planetary science)","level":2,"score":0.5137404203414917},{"id":"https://openalex.org/C2776999253","wikidata":"https://www.wikidata.org/wiki/Q1304270","display_name":"Combination therapy","level":2,"score":0.5019128322601318},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.45645686984062195},{"id":"https://openalex.org/C3019864225","wikidata":"https://www.wikidata.org/wiki/Q5867482","display_name":"Combination chemotherapy","level":3,"score":0.43475329875946045},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4227757453918457},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.37626540660858154},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3484511077404022},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.07345819473266602},{"id":"https://openalex.org/C87355193","wikidata":"https://www.wikidata.org/wiki/Q411","display_name":"Astrobiology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000077146","descriptor_name":"Irinotecan","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002166","descriptor_name":"Camptothecin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D002166","descriptor_name":"Camptothecin","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D004338","descriptor_name":"Drug Combinations","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005472","descriptor_name":"Fluorouracil","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011759","descriptor_name":"Pyrrolidines","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013274","descriptor_name":"Stomach Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D013941","descriptor_name":"Thymine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014271","descriptor_name":"Trifluridine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D014498","descriptor_name":"Uracil","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D014498","descriptor_name":"Uracil","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D015179","descriptor_name":"Colorectal Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D023041","descriptor_name":"Xenograft Model Antitumor Assays","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:25750295","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/25750295","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anticancer research","raw_type":"Journal Article"},{"id":"mag:2125337286","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/25750295","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9763000011444092}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":32,"referenced_works":["https://openalex.org/W296826252","https://openalex.org/W1533127962","https://openalex.org/W1751787421","https://openalex.org/W1925168260","https://openalex.org/W1974054076","https://openalex.org/W1976239753","https://openalex.org/W1980850901","https://openalex.org/W1990663467","https://openalex.org/W2010991676","https://openalex.org/W2011242930","https://openalex.org/W2019925885","https://openalex.org/W2020359797","https://openalex.org/W2021102443","https://openalex.org/W2025641756","https://openalex.org/W2045370737","https://openalex.org/W2053662276","https://openalex.org/W2079363774","https://openalex.org/W2086299451","https://openalex.org/W2094052679","https://openalex.org/W2097121246","https://openalex.org/W2097820456","https://openalex.org/W2102172720","https://openalex.org/W2102241419","https://openalex.org/W2123965006","https://openalex.org/W2141434947","https://openalex.org/W2143743735","https://openalex.org/W2147834058","https://openalex.org/W2151134466","https://openalex.org/W2151760576","https://openalex.org/W2156128049","https://openalex.org/W2156700619","https://openalex.org/W2164411042"],"related_works":["https://openalex.org/W1949863012","https://openalex.org/W2104077798","https://openalex.org/W2565235280","https://openalex.org/W2503821338","https://openalex.org/W2324737610","https://openalex.org/W2011242930","https://openalex.org/W2034411212","https://openalex.org/W2217202005","https://openalex.org/W2897057835","https://openalex.org/W1544633006"],"abstract_inverted_index":{"TAS-102":[0,20,60,77,146,186],"is":[1,41,189],"a":[2,15,56,68,82,123,190],"novel":[3],"oral":[4],"nucleoside":[5],"antitumor":[6],"agent":[7],"consisting":[8],"of":[9,18,31,51,59,142,154,185],"trifluridine":[10],"and":[11,61,70,89,97,109,139,165,187],"tipiracil":[12],"hydrochloride":[13,63],"at":[14],"molar":[16],"ratio":[17],"1:0.5.":[19],"was":[21,65,78,91,102,114,127,175],"approved":[22],"in":[23,25,67,172],"Japan":[24],"March":[26],"2014":[27],"for":[28,159,194,201,206],"the":[29,47,52,106,110,118,131,140,143,183],"treatment":[30,192],"patients":[32],"with":[33,147,161],"unresectable,":[34],"advanced":[35],"or":[36,196],"recurrent":[37,207],"colorectal":[38,69,195],"cancer":[39,72],"that":[40,126,182],"refractory":[42],"to":[43,87,121,152],"standard":[44],"therapies.":[45],"In":[46],"present":[48,178],"study,":[49],"enhancement":[50],"therapeutic":[53],"efficacy":[54],"using":[55],"combination":[57,184],"therapy":[58],"irinotecan":[62],"(CPT-11)":[64],"evaluated":[66,103],"gastric":[71,197],"xenograft-bearing":[73],"nude":[74],"mouse":[75],"model.":[76],"orally":[79],"administered":[80,92],"twice":[81],"day":[83,85],"from":[84],"1":[86,96],"14,":[88],"CPT-11":[90,148,188],"intravenously":[93],"on":[94,105,117],"days":[95],"8.":[98],"The":[99,135,177],"growth-inhibitory":[100,137],"activity":[101,138],"based":[104,116],"tumor":[107,124,136],"volume":[108,125,133],"growth-delay":[111],"period,":[112],"which":[113],"estimated":[115],"period":[119],"required":[120],"reach":[122],"five-times":[128],"greater":[129],"than":[130],"initial":[132],"(RTV5).":[134],"RTV5":[141],"group":[144],"receiving":[145],"were":[149],"significantly":[150],"superior":[151],"those":[153],"both":[155],"agents":[156],"as":[157],"monotherapy":[158],"mice":[160],"KM12C,":[162],"KM12C/5-FU,":[163],"DLD-1/5-FU,":[164],"SC-2":[166],"xenografts":[167],"(p<0.01).":[168],"No":[169],"significant":[170],"decrease":[171],"body":[173],"weight":[174],"observed.":[176],"pre-clinical":[179],"findings":[180],"indicated":[181],"promising":[191],"option":[193],"cancer,":[198],"not":[199],"only":[200],"chemo-na\u00efve":[202],"tumors,":[203],"but":[204],"also":[205],"tumors":[208],"after":[209],"5-fluorouracil":[210],"(5-FU)-based":[211],"chemotherapy.":[212]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":5},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":4},{"year":2017,"cited_by_count":6},{"year":2016,"cited_by_count":7},{"year":2015,"cited_by_count":4}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}